Drug class
Antipsychotics, Atypical
Atypical antipsychotics, also known as second-generation antipsychotics, are a diverse class of psychotropic medications characterized by a lower risk of extrapyramidal symptoms compared to first-generation agents. Read more about Antipsychotics, Atypical
296 drugs in this class 122 manufacturers
Drugs in Antipsychotics, Atypical
PALIPERIDONE ER (paliperidone)
CLOZAPINE
LURASIDONE HCL
PALIPERIDONE ER (paliperidone)
LURASIDONE HCL
ARIPIPRAZOLE
LURASIDONE HCL
OLANZAPINE
Atypical antipsychotics, also known as second-generation antipsychotics, are a diverse class of psychotropic medications characterized by a lower risk of extrapyramidal symptoms compared to first-generation agents.
They primarily exert their therapeutic effects through combined antagonism or partial agonism of central dopamine D2 receptors alongside antagonism of serotonin 5-HT2A receptors, though individual agents vary in their affinity for other neuroreceptors.
This drug class is widely utilized in the treatment of schizophrenia, schizoaffective disorder, and bipolar disorder, as well as adjunctive therapy in treatment-resistant major depressive disorder.
-
nih.gov
Atypical antipsychotics, also known as second-generation antipsychotics, are a diverse class of psychotropic medications characterized by a lower risk of extrapyramidal symptoms compared to first-generation agents
-
nih.gov
Atypical antipsychotics, also known as second-generation antipsychotics, are a diverse class of psychotropic medications characterized by a lower risk of extrapyramidal symptoms compared to first-generation agents They primarily exert their therapeutic effects through combined antagonism or partial agonism of central dopamine D2 receptors alongside antagonism of serotonin 5-HT2A receptors, though individual agents vary in their affinity for other neuroreceptors This drug class is widely utilized...
-
nih.gov
They primarily exert their therapeutic effects through combined antagonism or partial agonism of central dopamine D2 receptors alongside antagonism of serotonin 5-HT2A receptors, though individual agents vary in their affinity for other neuroreceptors
-
cms.gov
This drug class is widely utilized in the treatment of schizophrenia, schizoaffective disorder, and bipolar disorder, as well as adjunctive therapy in treatment-resistant major depressive disorder
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.